BAKER BROS. ADVISORS LP Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$17279.2T
Holdings
107
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (107 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | FGENEURFibroGen, Inc. | 238,084 | $642.8B | 0.00% | |
| 102 | NKTXNkarta, Inc. | 271,329 | $594.2B | 0.00% | |
| 103 | TARAProtara Therapeutics, Inc. | 199,671 | $477.2B | 0.00% | |
| 104 | —Genetron Holdings Limited | 455,306 | $423.5B | 0.00% | |
| 105 | FHTXFoghorn Therapeutics Inc. | 45,027 | $317.0B | 0.00% | |
| 106 | —Vincerx Pharma, Inc. | 225,579 | $293.3B | 0.00% | |
| 107 | SRZNWSurrozen, Inc. | 833,333 | $46.0B | 0.00% |
PreviousPage 2 of 2